[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier to attend LIVE "Market on Close" program each Friday with John Rowland. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Bausch & Lomb Corp (BLCO)

Bausch & Lomb Corp (BLCO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,309,245
  • Shares Outstanding, K 357,044
  • Annual Sales, $ 5,101 M
  • Annual Income, $ -360,000 K
  • EBIT $ 477 M
  • EBITDA $ 916 M
  • 60-Month Beta 0.58
  • Price/Sales 1.04
  • Price/Cash Flow 8.91
  • Price/Book 0.82
  • Price/Earnings ttm 22.86
  • Earnings Per Share ttm 0.65
  • Most Recent Earnings $0.08 on 04/29/26
  • Next Earnings Date 07/29/26
  • Annual Dividend & Yield (Fwd) 0.00 (0.00%)
  • Most Recent Dividend N/A on N/A
  • Sector Medical
  • INDUSTRY GROUPING:

    SIC-3851 Ophthalmic Goods

    Medical Services

Options Overview Details

View History
  • Implied Volatility 129.05% (+78.45%)
  • Historical Volatility 21.04%
  • IV Percentile 93%
  • IV Rank 63.04%
  • IV High 187.31% on 11/19/25
  • IV Low 29.66% on 05/12/26
  • Expected Move (DTE 27) 1.02 (6.86%)
  • Put/Call Vol Ratio 0.03
  • Today's Volume 1,821
  • Volume Avg (30-Day) 189
  • Put/Call OI Ratio 0.06
  • Today's Open Interest 5,721
  • Open Int (30-Day) 5,054
  • Expected Range 13.85 to 15.89

Analyst Rating / Earnings Estimates

Current Rating
See More
Moderate Buy
Based on 14 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $0.16
  • Number of Estimates 5
  • High Estimate $0.21
  • Low Estimate $0.14
  • Prior Year $0.07
  • Growth Rate Est. (year over year) +128.57%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.65 +1.50%
on 06/17/26
16.34 -9.02%
on 05/20/26
-1.24 (-7.70%)
since 05/18/26
3-Month
14.65 +1.50%
on 06/17/26
17.12 -13.14%
on 04/17/26
-1.15 (-7.18%)
since 03/18/26
52-Week
11.58 +28.46%
on 06/20/25
18.92 -21.39%
on 02/25/26
+3.32 (+28.74%)
since 06/18/25

Most Recent Stories

More News
Bausch + Lomb Launches Blink® Triple Care Preservative Free Lubricant Eye Drops in the United States

Blink Triple Care Preservative Free eye drops are made with the same clinically proven formula as Blink Triple Care and provide up to 10 hours of dry eye symptom relief‡ ...

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
Bausch + Lomb to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that Chairman and CEO Brent Saunders and Chief Medical...

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
Bausch + Lomb Announces 2026 Annual Meeting of Shareholder Results

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced the election of the 10 directors nominated at its...

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest

Medical Devices & Supplies - Specialty Stocks Q1 Teardown: Bausch + Lomb (NYSE:BLCO) Vs The Rest

BLCO : 14.87 (+0.07%)
Bausch + Lomb Launches PreserVision AREDS3™ Eye Vitamins in the United States

PreserVision AREDS3™ eye vitamins combine clinically proven AREDS2 nutrients recommended by the National Eye Institute (NEI) to help reduce the risk of moderate-to-advanced age-related macular...

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We’re Skeptical Of

FTV : 61.03 (+0.58%)
KD : 11.00 (-3.93%)
BLCO : 14.87 (+0.07%)
Bausch + Lomb Launches Bi-Blade+™ Dual-Port Vitrectomy Cutter in Europe

Increased cutting speed of 25,000 cuts per minute 1 is designed to minimize retinal traction, 2 increase vitreous flow 1 and reduce infusion pressure...

BLCO : 14.87 (+0.07%)
Bausch + Lomb Announces Second R&D “Teach-in” Webinar

Event will feature detailed overviews of two innovative contact lens technologies with potential to redefine the standard of care

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
Bausch + Lomb to Feature More Than 40 Scientific Studies at the 2026 Association for Research in Vision and Ophthalmology Annual Meeting

Bausch + Lomb Corporation (NYSE/TSX: BLCO), a leading global eye health company dedicated to helping people see better to live better, today announced that it will deliver more than 40 scientific data...

BLCO.TO : 20.61 (-2.04%)
BLCO : 14.87 (+0.07%)
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026

BLCO : 14.87 (+0.07%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Sell with a Strongest short term outlook on maintaining the current direction.

See More Share

Business Summary

Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R)....

See More

Key Turning Points

3rd Resistance Point 15.15
2nd Resistance Point 15.08
1st Resistance Point 14.97
Last Price 14.87
1st Support Level 14.79
2nd Support Level 14.72
3rd Support Level 14.61

See More

52-Week High 18.92
Fibonacci 61.8% 16.11
Fibonacci 50% 15.25
Last Price 14.87
Fibonacci 38.2% 14.38
52-Week Low 11.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.